Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for AKI prevention in EVAR
NCT04766047Unknown
- Sponsor
- University of Thessaly
- Start
- Aug 2021
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of dexmedetomidine in acute kidney injury (AKI), sponsored by University of Thessaly. Primary endpoint: Incidence of Acute Kidney Injury at 1 day. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT04766047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04766047.